Breast Cancer Diagnosis Articles & Analysis: Older
23 news found
Cirdan are delighted to announce that together with Queen’s University Belfast and our KTP Associate and Senior AI Engineer, Jonathan Armstrong, we have been selected as the winners of the Best KTP project by Innovate UK. Innovate UK’s Best Knowledge Transfer Partnership award honours the KTP which has brought the greatest benefits to all three participants, exceeding the expectations ...
October marks a month dedicated to a cause close to the core of everything which we do at Cirdan: Breast Cancer Awareness. This month will see a surge in activism surrounding breast cancer awareness and a push for finding a cure from around the globe. The fight to treat and cure breast cancer continues constantly, and we pride ourselves in taking part in the fight to save lives. Breast cancer ...
Cirdan are delighted to announce that together with Queen’s University Belfast and our KTP Associate and Senior AI Engineer, Jonathan Armstrong, we have been shortlisted for Innovate UK’s esteemed Best Knowledge Transfer Partnership Award. Innovate UK’s Best Knowledge Transfer Partnership award honours the KTP which has brought the greatest benefits to all three participants, ...
(Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, announced an educational partnership supporting Worldwide Breast Cancer’s “Know Your Lemons” campaign starting with the Netherlands, which has one of the highest breast ...
"I am thrilled to be part of such an impressive team of scientists, researchers and developers focused on early breast cancer detection, prediction and diagnosis. AI has matured since the early 2000s, and is now poised to be a leading clinical decision support tool, assisting radiologists and other clinicians in the global fight to improve ...
“Clinical research has shown that delays in breast cancer diagnosis can lead to worse outcomes, including the risk of the cancer metastasizing, decreased survivorship, and increased treatment costs,” comments Peter Kecskemethy, Kheiron’s Chief Executive Officer. ...
Aidoc’s comprehensive AI continues to expand to cover the majority of radiology adult subspecialties Aidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and 3D mammography, today announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging ...
ByAidoc
IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced the advancement of its regulatory strategy in China with the submission of an amendment to the registration certificate for the IceSense3® system, which was granted ...
In Nigeria, breast cancer is becoming the major health problem, representing nearly 25% of all new cancer diagnoses in the country. The parties at the signing ceremony have agreed to co-develop Breast Cancer Centers of Excellence which will deliver comprehensive, compassionate breast ...
“It goes to show how excited people are about our mission and demonstrates people’s desire to help millions of women around the world avoid later-stage breast cancer diagnoses.” The company aims to raise a maximum of $5M via Republic. ...
“The anxiety and distress associated with waiting for a confirmed cancer diagnosis has a marked detrimental impact on patients and their families’ quality of life and finances,” said Dr. ...
An artificial intelligence (AI)-based breast ultrasound software from Koios Medical, Inc. proven to significantly enhance the accuracy and consistency of lesion assessment for physicians across a wide range of experience levels, per a study recently published in the American Journal of Roentgenology, is now being used to diagnose breast cancer earlier for patients with appointments cancelled due ...
Dilon Technologies® Inc., a world class global leader in breast cancer treatment and diagnosis and owner of the Navigator Gamma Probes has acquired substantially all the assets of Dune Medical, including Marginprobe’s “MarginProbe”. “With the acquisition of the MarginProbe, Dilon will now offer the only FDA approved ...
Sponsored by the international breast cancer charity, the Know Your Lemons Foundation focuses on breast health education to overcome taboos, fears, and literacy issues. ...
® (Seno Medical) to diagnose breast cancer. The technology may offer physicians a new, non-invasive tool to not only better differentiate between benign and malignant breast cancers, but may also help differentiate between breast cancer molecular subtypes. ...
(Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge ...
(Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic (OA/US) imaging to differentiate benign from malignant masses, reported results of a study demonstrating that morphologic and functional OA/US features provide a non-invasive approach to helping distinguish breast cancer ...
Raising Awareness Seno Medical initiated a building-wide Breast Cancer Awareness Day at the Callaghan Tower in the medical center district of San Antonio. ...
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is again a major sponsor of the annual European Congress of Pathology. ...
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced positive findings in a white paper by ProPath Services comparing Dako's HER2 IQFISH pharmDx kit with Abbott's PathVysion HER-2 DNA Probe kit. ProPath Services is an independent anatomic pathology laboratory headquartered in Dallas, Texas. The white paper, written by Debra S. Cohen, BS, ...